Ransomware still a top cybersecurity threat, warns Verizon 2018 Data Breach Investigations Report
Apr 10, 2018 04:01 am UTC| Business
Ransomware attacks double since 2017, and now target business critical systems Ransomware is the more prevalent variety of malicious software, found in 39 percent of malware-related cases.Human factor continues to be a...
ImageWare® Provides Sales Update of GoVerifyID® Biometric Authentication Technology
Apr 10, 2018 04:00 am UTC| Business
SAN DIEGO, April 09, 2018 -- ImageWare® Systems, Inc. (OTCQB:IWSY), a leader in mobile and cloud-based, multi-modal biometric identity management solutions, provides its first sales update for 2018. Jim Miller,...
CLEARink Wins the Frost & Sullivan 2018 Technology Innovation Award
Apr 10, 2018 01:00 am UTC| Business
BEIJING, April 10, 2018 -- CLEARink Displays Inc, the leader in next-generation ePaper, announced today that it has won the Frost Sullivan 2018 Technology Innovation Award for its reflective display technology. ...
Update: Boyden Places Board Members for Goodwill Industries International
Apr 10, 2018 00:40 am UTC| Business
Atlanta, April 09, 2018 -- Boyden, a premier leadership and talent advisory firm, has announced that it partnered in the placements of Joe Guith, President of McAlister’s Deli, Matthew Wadiak, Co-Founder of Blue Apron,...
Diversegy an IDT Company Announces New Venture with Central Energy USA
Apr 09, 2018 23:26 pm UTC| Business
KING OF PRUSSIA, Pa., April 09, 2018 -- Central Energy USA officially launched their Joint Venture this week with Diversegy, the prominent Energy Broker part of the IDT Family of energy related companies such as Genie...
Nomura Is No. 1 on Institutional Investor’s 25th Annual All-Japan Research Team Survey
Apr 09, 2018 23:00 pm UTC| Business
NEW YORK, April 09, 2018 -- As the economic growth in Japan continues for an eighth consecutive quarter, so does the battle for excellence among Japanese sell-side researchers as demonstrated by the leaders of the...
Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology
Apr 09, 2018 22:45 pm UTC| Business
CAMBRIDGE, Mass., April 09, 2018 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage company developing novel epigenetic therapies, announced today its first-in-human data on the effects of EZH2 inhibition in patients with...